Precision fluid and vasoactive drug therapy for critically ill patients

Area of Science:

• Critical care medicine
• Pharmacology
• Evidence-based practice

Background:

• Clinical practice guidelines for fluid and vasoactive therapies in critically ill adults often rely on low-quality evidence.
• Existing guidelines may not incorporate recent landmark trials, such as those comparing balanced crystalloids and normal saline.
• Precision medicine is a recognized research priority for optimizing fluid and vasoactive therapy in critical illness.

Purpose of the Study:

• To review the evaluation and challenges of implementing precision fluid and vasoactive therapies in adult critically ill patients.
• To discuss recent investigations that may influence future clinical practice guidelines and bedside care.
• To highlight the importance of personalized approaches in critical care fluid management.

Main Methods:

• Narrative review of existing literature and clinical practice guidelines.
• Inclusion of recent investigations published after current guideline releases.
• Analysis of the integration of precision medicine in critical care fluid and vasoactive therapy.

Main Results:

• Current guidelines for critical care fluid and vasoactive therapies are often based on limited evidence.
• The integration of precision medicine into these guidelines is not yet widespread but is a key research area.
• Recent trials provide new insights that could reshape future recommendations.

Conclusions:

• There is a need to update clinical practice guidelines with higher quality evidence and incorporate precision medicine for fluid and vasoactive therapies.
• Personalized approaches are crucial for tailoring critical care interventions to patient-specific needs.
• Future research should focus on advancing precision medicine in critical illness to improve patient outcomes.